Another study showed that the serum of IL-6 was significantly elevated in patients with idiopathic and hereditary PAH (IPAH and HPAH), and that IL-6 as a prognosis predictor was better than traditional predictors such as six-minute walking distance and hemodynamics in Group 1 PAH patients (22). Here, IL6 is linked to pulmonary arterial hypertension.